#University of Colorado Cancer Center

“We’re taking what we know from human cancers and applying it in canine cancers.”

Chance and randomness certainly play major roles in deciding which individuals get cancer. But the dice are loaded.

The results from an innovative, “virtual” clinical trial were presented at the 2019 ASCO Annual Meeting.

Three studies from the University of Colorado explain radiotherapy resistance and how to reduce it.

“We wanted to understand how these precancerous cells may impact neighboring cancer,” says Christian Young, PhD.

Identifying a tumor’s genetic mutations brings researchers closer to predicting treatment response.

“If you have symptoms, please be an advocate for yourself. Listen to your body, and get yourself checked out.”

“Our goal is to make cancer survivors feel like they’re part of a team,” says study author Heather Leach, PhD.

The results describe the challenges people ages 18 to 39 face during and after treatment.

Not only was he diagnosed with testicular cancer at 23, but when a lung tumor resisted treatment, Daniel needed total lung removal surgery.

The major goal is to understand why the incidence of disease is increasing in young people, for the purposes of prevention and treatment.

During treatments, Tim Reagan says it was hard to get up each day to walk his dog, Brady. But getting up and out was exactly what he needed.

“I wanted to do something meaningful,” said Emily Daniels after her ALK-positive lung cancer diagnosis in 2018.

Guidelines are continuing to evolve to meet the changing landscape of cancer and the new technologies to find and treat it.

Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.

Ongoing work hopes to discover if interventions designed to boost caregiver wellbeing could boost patient outcomes.